Claire C. Nestor

Nov 6, 2024 | associationofanaesthetists-publications.onlinelibrary.wiley.com | Paul Stewart |Cillian Clancy |Michael G. Irwin |Claire C. Nestor

Introduction Sodium-glucose co-transporter 2 inhibitors are a novel class of antihyperglycaemic drugs used in the management of type 2 diabetes, that improve glycaemic control, cardiovascular outcomes and promote weight loss. They are also approved for the treatment of heart failure and chronic kidney disease in patients with or without diabetes.